Inhibition of platelet aggregation after administration of three different ticagrelor loading dose formulations in patients with stable angina referred for coronary angiography

Trial Profile

Inhibition of platelet aggregation after administration of three different ticagrelor loading dose formulations in patients with stable angina referred for coronary angiography

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jan 2017

At a glance

  • Drugs Ticagrelor (Primary)
  • Indications Angina pectoris
  • Focus Therapeutic Use
  • Acronyms IPAAD-Tica
  • Most Recent Events

    • 02 Mar 2016 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 15 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top